RE: Neuphoria Merger28 Jun 2026 22:41
Miavoce,
I guess that what the discussions are all about.
Currently, "the markets" value SCLP at £200m and NEUP at £20m - that is 10%.
Most of the value in NEUP is cash in the bank so difficult to argue against their valuation.
They could argue that Scancell is worth more (as we believe it is but these sorts of deals tend to use recent SP history. If either party aren't happy, they walk away. That is why it is not yet a "done deal"